Home > About us > Profile

Profile

 Founded in 1996, Shanghai Shyndec (Modern) Pharmaceutical Co., Ltd., wholly-owned subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM), is a comprehensive manufacturer of pharmaceuticals, including APIs, pharmaceutical intermediates and finished drug products.
 
 Mainly held by China National Institute of Pharmaceutical Industry, the most famous pharmaceutical research institute in China, Shanghai Shyndec is a high-tech and research driven company. It focuses on the integration of R&D and production resources  to provide its global customers with outstanding products and services.
 
 Shanghai Shyndec has three API manufacturing factories, four finished drug factories and one R&D center. It also holds six companies involving APIs & finished drug factories, bio-pharmaceuticals, pharmaceutical consulting, international trading, etc.
 
 The stock of Shanghai Shyndec (600420) come publicly on Shanghai stock market in 2004. The total revenue in 2010 is more than 210 million US dollars. At present most of the products have passed the National GMP authentication. And the API of Alpha lipoic acid has been granted CEP certificate by EDQM.
2011-06-19[Back]
Related Articles
 We will attend the API SUZHOU EXHIBITION in China from Nov....
 We will attend the CPHI Frankfurt from Oct. 22 to 24, 2013 at the booth 30G46....
We will attend the CPHI Shanghai from Jun 25 to 27, 2013 at the booth W1D12....
We will attend the API WUHAN...